BCM
RVMD icon

Burrage Capital Management’s Revolution Medicines RVMD Stock Holding History

Burrage Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$1.59M – 16
2021
Q2 		$1.59M Buy
+50,000
New +$1.75M 1.59% 19

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Burrage Capital Management's RVMD Position: Q3 2021 in Review

Burrage Capital Management sold out of Revolution Medicines (RVMD) in Q3 2021, closing a stake of 50,000 shares — an estimated $1.59M sold.

Burrage Capital Management first reported a position in RVMD in Q2 2021 and held it in 1 quarter. The position peaked at $1.59M in Q2 2021. 114 funds tracked by Wall St. Rank hold RVMD as of Q3 2021.

  • Burrage Capital Management reported no remaining Revolution Medicines position as of Q3 2021 after selling out during the quarter.
  • Burrage Capital Management sold 50,000 Revolution Medicines shares in Q3 2021, an estimated $1.59M.
  • Burrage Capital Management first reported a position in Revolution Medicines in Q2 2021 and held it in 1 quarter.
  • Burrage Capital Management's Revolution Medicines position peaked at $1.59M in Q2 2021.
  • 114 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2021.

Based on Burrage Capital Management's 13F filing for Q3 2021.